Zobrazeno 1 - 10
of 167
pro vyhledávání: '"John K. Choi"'
Autor:
Jennifer L. Kamens, Stephanie Nance, Cary Koss, Beisi Xu, Anitria Cotton, Jeannie W. Lam, Elizabeth A. R. Garfinkle, Pratima Nallagatla, Amelia M. R. Smith, Sharnise Mitchell, Jing Ma, Duane Currier, William C. Wright, Kanisha Kavdia, Vishwajeeth R. Pagala, Wonil Kim, LaShanale M. Wallace, Ji-Hoon Cho, Yiping Fan, Aman Seth, Nathaniel Twarog, John K. Choi, Esther A. Obeng, Mark E. Hatley, Monika L. Metzger, Hiroto Inaba, Sima Jeha, Jeffrey E. Rubnitz, Junmin Peng, Taosheng Chen, Anang A. Shelat, R. Kiplin Guy, Tanja A. Gruber
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
KMT2A rearranged infant acute lymphoblastic leukemia patients have a poor prognosis. Here, the authors use high throughput drug screening on primary infant specimens to identify a clinically active chemotherapy combination.
Externí odkaz:
https://doaj.org/article/2cd886b587c94bdaa2bd04fdff849913
Autor:
Jennifer L. Kamens, Stephanie Nance, Cary Koss, Beisi Xu, Anitria Cotton, Jeannie W. Lam, Elizabeth A. R. Garfinkle, Pratima Nallagatla, Amelia M. R. Smith, Sharnise Mitchell, Jing Ma, Duane Currier, William C. Wright, Kanisha Kavdia, Vishwajeeth R. Pagala, Wonil Kim, LaShanale M. Wallace, Ji-Hoon Cho, Yiping Fan, Aman Seth, Nathaniel Twarog, John K. Choi, Esther A. Obeng, Mark E. Hatley, Monika L. Metzger, Hiroto Inaba, Sima Jeha, Jeffrey E. Rubnitz, Junmin Peng, Taosheng Chen, Anang A. Shelat, R. Kiplin Guy, Tanja A. Gruber
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/9c447ea95d6141ec876fcaed7f440b4c
Autor:
Ching-Hon Pui, Deqing Pei, Cheng Cheng, Suzanne L. Tomchuck, Scarlett N. Evans, Hiroto Inaba, Sima Jeha, Susana C. Raimondi, John K. Choi, Paul G. Thomas, Mari Hashitate Dallas
Publikováno v:
OncoImmunology, Vol 8, Iss 8 (2019)
T-cell malignancies expressing the γδ T-cell receptor (TCR) are often associated with poor prognosis. Here, we determined the clinical outcome of pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) expressing the γδ TCR. Of 100 ne
Externí odkaz:
https://doaj.org/article/ce3e80a9e8ca4eb1bcc52fb5be993c6a
Autor:
Eric X. Wei, Vasiliki Leventaki, John K. Choi, Susana C. Raimondi, Elizabeth M. Azzato, Sheila A. Shurtleff, Menchu G. Ong, Diana M. Veillon, James D. Cotelingam, Rodney E. Shackelford
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Gamma delta (γδ) T-cell antigen receptor (TCR) expression and its related T-cell differentiation are not commonly reported in T-cell acute lymphoblastic leukemia/lymphoma (T-ALL). Here we report two pediatric T-ALL cases and present their clinical
Externí odkaz:
https://doaj.org/article/81f1594caaf947f3b5fda567be040c4d
Autor:
John K. Choi, Paul E. Mead
Publikováno v:
Clinics in Laboratory Medicine. 43:115-125
Minimal residual disease detection provides critical prognostic predictor of treatment outcome and is the standard of care for B lymphoblastic leukemia. Flow cytometry-based minimal residual disease detection is the most common test modality and has
Autor:
Karen M. Chisholm, Jenny Smith, Amy E. Heerema‐McKenney, John K. Choi, Rhonda E. Ries, Betsy A. Hirsch, Susana C. Raimondi, Yi‐Cheng Wang, Alice Dang, Todd A. Alonzo, Lillian Sung, Richard Aplenc, Alan S. Gamis, Soheil Meshinchi, Samir B. Kahwash
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Cheng Cheng, Yinmei Zhou, Ching-Hon Pui, Matthew M. Klairmont, Tanja A. Gruber, Sima Jeha, John K. Choi, Hiroto Inaba, Yiwei Liu
Publikováno v:
Mod Pathol
Little is known about B-lymphoblastic leukemia (B-ALL) that lacks expression of terminal deoxynucleotidyl transferase (TdT). To address this, we performed the largest study to date of TdT-negative B-ALL using data from St. Jude Total XV and XVI clini
Autor:
Joseph D. Khoury, Eric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio, Jane F. Apperley, Rafael Bejar, Emilio Berti, Lambert Busque, John K. C. Chan, Weina Chen, Xueyan Chen, Wee-Joo Chng, John K. Choi, Isabel Colmenero, Sarah E. Coupland, Nicholas C. P. Cross, Daphne De Jong, M. Tarek Elghetany, Emiko Takahashi, Jean-Francois Emile, Judith Ferry, Linda Fogelstrand, Michaela Fontenay, Ulrich Germing, Sumeet Gujral, Torsten Haferlach, Claire Harrison, Jennelle C. Hodge, Shimin Hu, Joop H. Jansen, Rashmi Kanagal-Shamanna, Hagop M. Kantarjian, Christian P. Kratz, Xiao-Qiu Li, Megan S. Lim, Keith Loeb, Sanam Loghavi, Andrea Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P. Patel, Nikhil Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William Sewell, Reiner Siebert, Prashant Tembhare, Jeffrey Tyner, Srdan Verstovsek, Wei Wang, Brent Wood, Wenbin Xiao, Cecilia Yeung, Andreas Hochhaus
Publikováno v:
Leukemia, 36, 7, pp. 1703-1719
Leukemia
Leukemia, 2022, 36 (7), pp.1703-1719. ⟨10.1038/s41375-022-01613-1⟩
Leukemia, 36, 1703-1719
Khoury, J D, Solary, E, Abla, O, Akkari, Y, Alaggio, R, Apperley, J F, Bejar, R, Berti, E, Busque, L, Chan, J K C, Chen, W, Chen, X, Chng, W-J, Choi, J K, Colmenero, I, Coupland, S E, Cross, N C P, de Jong, D, Elghetany, M T, Takahashi, E, Emile, J-F, Ferry, J, Fogelstrand, L, Fontenay, M, Germing, U, Gujral, S, Haferlach, T, Harrison, C, Hodge, J C, Hu, S, Jansen, J H, Kanagal-Shamanna, R, Kantarjian, H M, Kratz, C P, Li, X-Q, Lim, M S, Loeb, K, Loghavi, S, Marcogliese, A, Meshinchi, S, Michaels, P, Naresh, K N, Natkunam, Y, Nejati, R, Ott, G, Padron, E, Patel, K P, Patkar, N, Picarsic, J, Platzbecker, U, Roberts, I, Schuh, A, Sewell, W, Siebert, R, Tembhare, P, Tyner, J, Verstovsek, S, Wang, W, Wood, B, Xiao, W, Yeung, C & Hochhaus, A 2022, ' The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours : Myeloid and Histiocytic/Dendritic Neoplasms ', Leukemia, vol. 36, no. 7, pp. 1703-1719 . https://doi.org/10.1038/s41375-022-01613-1
Leukemia
Leukemia, 2022, 36 (7), pp.1703-1719. ⟨10.1038/s41375-022-01613-1⟩
Leukemia, 36, 1703-1719
Khoury, J D, Solary, E, Abla, O, Akkari, Y, Alaggio, R, Apperley, J F, Bejar, R, Berti, E, Busque, L, Chan, J K C, Chen, W, Chen, X, Chng, W-J, Choi, J K, Colmenero, I, Coupland, S E, Cross, N C P, de Jong, D, Elghetany, M T, Takahashi, E, Emile, J-F, Ferry, J, Fogelstrand, L, Fontenay, M, Germing, U, Gujral, S, Haferlach, T, Harrison, C, Hodge, J C, Hu, S, Jansen, J H, Kanagal-Shamanna, R, Kantarjian, H M, Kratz, C P, Li, X-Q, Lim, M S, Loeb, K, Loghavi, S, Marcogliese, A, Meshinchi, S, Michaels, P, Naresh, K N, Natkunam, Y, Nejati, R, Ott, G, Padron, E, Patel, K P, Patkar, N, Picarsic, J, Platzbecker, U, Roberts, I, Schuh, A, Sewell, W, Siebert, R, Tembhare, P, Tyner, J, Verstovsek, S, Wang, W, Wood, B, Xiao, W, Yeung, C & Hochhaus, A 2022, ' The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours : Myeloid and Histiocytic/Dendritic Neoplasms ', Leukemia, vol. 36, no. 7, pp. 1703-1719 . https://doi.org/10.1038/s41375-022-01613-1
The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database. This paper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e505729c9f9bde8ff82d51d719fed2e
http://hdl.handle.net/10044/1/103319
http://hdl.handle.net/10044/1/103319
Autor:
Soheil Meshinchi, Betsy A. Hirsch, Samir B. Kahwash, Jessica A. Pollard, John E. Levine, Brian T. Fisher, Terzah M. Horton, Richard Aplenc, Lillian Sung, Susana C. Raimondi, Todd A. Alonzo, Lisa Eidenschink Brodersen, Alan S. Gamis, Michael R. Loken, Edward A. Kolb, John K. Choi, Robert B. Gerbing
Publikováno v:
Haematologica
New therapeutic strategies are needed for pediatric acute myeloid leukemia (AML) to reduce disease recurrence and treatment-related morbidity. The Children’s Oncology Group Phase III AAML1031 trial tested whether the addition of bortezomib to stand
Autor:
Alan S. Gamis, Robert B. Gerbing, Betsy A. Hirsch, Richard Aplenc, John K. Choi, Lillian Sung, Michael R. Loken, Soheil Meshinchi, Kelly D. Getz, Samir B. Kahwash, E. Anders Kolb, Todd A. Alonzo, Susana C. Raimondi, Lisa Eidenschink Brodersen
Publikováno v:
Pediatr Blood Cancer
Background The optimal number of chemotherapy courses for low-risk (LR) pediatric acute myeloid leukemia (AML) is not known. Objective To compare outcomes for four (21.6 g/m2 cytarabine) versus five (45.6 g/m2 cytarabine) chemotherapy courses for LR-